Incyte Stock Slumps After Firm Scraps Drug, Pauses Enrollment in Other Study
Incyte led S&P 500 decliners Tuesday afternoon after the pharmaceutical firm said it will stop developing one drug and pause ...
Incyte Is the S&P 500’s Worst Performer Today. What’s Hitting the Stock.
William Blair analysts led by Matt Phipps, who rate Incyte at Outperform, called the news disappointing. They highlighted ...
Verywell Mind on MSN17 小时
This Is What Happens in Your Brain When You’re Anxious, According to Experts
But have you ever wondered what's actually going on in your brain when you have anxiety? A lot of it comes down to chemicals.
S&P 500 Gains and Losses Today: Supermicro Roars Back After Compliance Filing
The S&P 500 added 0.4% on Tuesday, Nov. 19, as investors digested a strong report from a major retailer and awaited more ...
Univeristy of Iowa Daily Iowan8 小时
Iowa City residents, DNR, EPA, work together to search for sources of pollution
Eleven months ago, Iowa City residents asked for an answer and claim they heard silence in return. Men and women who allege ...
WTOP News18 小时
Allergies: Types, Symptoms and How to Find Relief
More than 50 million Americans suffer from allergies — making allergies the sixth leading cause of chronic illness in the United States, according to the Centers for Disease Control and Prevention.